Quality Assurance Issues in Conducting Multi-Institutional Advanced Technology Clinical Trials

James A. Purdy

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


The National Cancer Institute-sponsored Advanced Technology Quality Assurance (QA) Consortium, which consisted of the Image-Guided Therapy QA Center, Radiation Therapy Oncology Group, Radiological Physics Center, Quality Assurance Review Center, and Resource Center for Emerging Technologies, has pioneered the development of an infrastructure and QA method for advanced technology clinical trials that requires volumetric digital data submission of a protocol patient's treatment plan and verification data. In particular, the Image-Guided Therapy QA Center has nearly 15 years experience in facilitating QA review for Radiation Therapy Oncology Group advanced technology clinical trials. This QA process includes (1) a data integrity review for completeness of protocol required elements, the format of data, and possible data corruption, and recalculation of dose-volume histograms; (2) a review of compliance with target volume and organ-at-risk contours by study chairs; and (3) a review of dose prescription and dose heterogeneity compliance by the Radiation Therapy Oncology Group Headquarters Dosimetry Group or the Radiological Physics Center dosimetrists (for brachytherapy protocols). This report reviews the lessons learned and the QA challenges presented by the use of advanced treatment modalities in clinical trials requiring volumetric digital data submission.

Original languageEnglish
Pages (from-to)S66-S70
JournalInternational Journal of Radiation Oncology Biology Physics
Issue number1 SUPPL.
StatePublished - May 1 2008


  • Advanced technology
  • Clinical trials
  • Quality assurance


Dive into the research topics of 'Quality Assurance Issues in Conducting Multi-Institutional Advanced Technology Clinical Trials'. Together they form a unique fingerprint.

Cite this